As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...